Ketamine stereoselectively affects vasorelaxation mediated by ATP-sensitive K(+) channels in the rat aorta

Anesthesiology. 2002 Oct;97(4):882-6. doi: 10.1097/00000542-200210000-00020.

Abstract

Background: The effect of ketamine on vasodilation mediated by adenosine triphosphate (ATP)-sensitive K(+) channels has not been studied. The present study was designed to determine whether ketamine might stereoselectively affect vasorelaxation induced by an ATP-sensitive K(+) channel opener in the isolated rat aorta.

Methods: Rings of the rat aorta with or without endothelium were suspended for isometric force recording. During contraction to phenylephrine (3 x 10(-7) M), vasorelaxation in response to an ATP-sensitive K(+) channel opener levcromakalim (10(-8) to 10(-5) M) or a nitric oxide donor sodium nitroprusside (10(-10) to 10(-5) M) was obtained. Glibenclamide (10(-5) M), S(+) ketamine (10(-4) M), or ketamine racemate (10(-5) to 10(-4) M) was applied 15 min before addition of phenylephrine.

Results: Vasorelaxation induced by levcromakalim was completely abolished by an ATP-sensitive K(+) channel antagonist glibenclamide (10(-5) M) in the aorta with or without endothelium. Ketamine racemate (3 x 10(-5) to 10(-4) M) significantly inhibited this vasorelaxation in a concentration-dependent fashion, whereas S(+) ketamine did not affect the relaxation. However, the highest concentration of ketamine racemate and S(+) ketamine used in the present study did not alter vasorelaxation in response to sodium nitroprusside in the aorta without endothelium.

Conclusion: In the isolated rat aorta, clinically relevant concentrations of ketamine racemate can inhibit relaxation induced by an ATP-sensitive K(+) channel opener, whereas S(+) ketamine did not produce any inhibitory effect on this vasorelaxation. These results suggest that ketamine stereoselectively alters vasodilation ATP-sensitive K(+) channels in the conduit artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters
  • Animals
  • Aorta, Thoracic / drug effects*
  • Cromakalim / pharmacology
  • Endothelium, Vascular / physiology
  • In Vitro Techniques
  • KATP Channels
  • Ketamine / chemistry*
  • Ketamine / pharmacology*
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Nitroprusside / pharmacology
  • Phenylephrine / pharmacology
  • Potassium Channels / agonists
  • Potassium Channels / drug effects*
  • Potassium Channels, Inwardly Rectifying
  • Rats
  • Rats, Wistar
  • Stereoisomerism
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*

Substances

  • ATP-Binding Cassette Transporters
  • KATP Channels
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Vasoconstrictor Agents
  • uK-ATP-1 potassium channel
  • Cromakalim
  • Nitroprusside
  • Phenylephrine
  • Ketamine